References
- 1Paz Ocaranza M, Riquelme JA, García L, Jalil JE, Chiong M, Santos RAS, Lavandero S. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17(2):116–129. DOI: 10.1038/s41569-019-0244-8
- 2Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
- 3Ajoolabady A, Pratico D, Dunn WB, Lip GYH, Ren J. Metabolomics: Implication in cardiovascular research and diseases. Obes Rev. 2024;25(12):
e13825 . DOI: 10.1111/obr.13825 - 4Suvila K, Niiranen TJ. Interrelations between high blood pressure, organ damage, and cardiovascular disease: No more room for doubt. Hypertension. 2022;79(3):516–517. DOI: 10.1161/HYPERTENSIONAHA.121.18786
- 5Baman JR, Ahmad FS. Heart failure. JAMA. 2020;324(10):
1015 . DOI: 10.1001/jama.2020.13310 - 6Batra AS, Silka MJ, Borquez A, Cuneo B, Dechert B, Jaeggi E, Kannankeril PJ, Tabulov C, Tisdale JE, Wolfe D. Pharmacological management of cardiac arrhythmias in the fetal and neonatal periods: A scientific statement from the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES). Circulation. 2024;149(10):e937–e952. DOI: 10.1161/CIR.0000000000001206
- 7Lu D, Fan X. Insights into the prospects of nanobiomaterials in treating cardiac arrhythmia. J Nanobiotechnology. 2024;22(1):
523 . DOI: 10.1186/s12951-024-02805-w - 8Brundel B, Ai X, Hills MT, Kuipers MF, Lip GYH, de Groot NMS. Atrial fibrillation. Nat Rev Dis Primers. 2022;8(1):
21 . DOI: 10.1038/s41572-022-00347-9 - 9Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic of the 20(th) century: coronary heart disease. Am J Med. 2014;127(9):807–812. DOI: 10.1016/j.amjmed.2014.04.015
- 10Hilkens NA, Casolla B, Leung TW, de Leeuw FE. Stroke. Lancet. 2024;403(10446):2820–2836. DOI: 10.1016/S0140-6736(24)00642-1
- 11Liew G, Wang JJ. Manifestaciones vasculares retinianas: >reflejan el estado del corazón? Revista Española de Cardiología. 2011;64(6):515–521. DOI: 10.1016/j.recesp.2011.02.014
- 12Zekavat SM, Raghu VK, Trinder M, Ye Y, Koyama S, Honigberg MC, Yu Z, Pampana A, Urbut S, Haidermota S, O’Regan DP, Zhao H, Ellinor PT, Segrè AV, Elze T, Wiggs JL, Martone J, Adelman RA, Zebardast N, Del Priore L, Wang JC, Natarajan P. Deep learning of the retina enables phenome- and genome-wide analyses of the microvasculature. Circulation. 2022;145:134–150. DOI: 10.1161/CIRCULATIONAHA.121.057709
- 13Rusu AC, Horvath KU, Tinica G, Chistol RO, Bulgaru-Iliescu AI, Todosia ET, Brînzaniuc K. Retinal structural and vascular changes in patients with coronary artery disease: A systematic review and meta-analysis. Life (Basel). 2024;14(4):
448 . DOI: 10.3390/life14040448 - 14Yang S, Zhu Z, Yuan Y, Chen S, Shang X, Bulloch G, He M, Wang W. Analysis of plasma metabolic profile on ganglion cell-inner plexiform layer thickness with mortality and common diseases. JAMA Netw Open. 2023;6(5):
e2313220 . DOI: 10.1001/jamanetworkopen.2023.13220 - 15Kong M, Kwun Y, Sung J, Ham DI, Song YM. Association between systemic hypertension and macular thickness measured by optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(4):2144–2150. DOI: 10.1167/iovs.14-16080
- 16Xie H, Pan Z, Xue CC, Chen D, Jonas JB, Wu X, Wang YX. Arterial hypertension and retinal layer thickness: The Beijing Eye Study. Br J Ophthalmol. 2023;108(1):105–111. DOI: 10.1136/bjo-2022-322229
- 17Papathanasiou KA, Kazantzis D, Vrachatis DA, Giotaki SG, Papaconstantinou E, Kanakis M, Avramides D, Deftereos S, Chatziralli I, Georgalas I. Choroidal thickness in patients with systemic arterial hypertension: A systematic review and meta-analysis. Ther Adv Ophthalmol. 2022;14:
25158414221132825 . DOI: 10.1177/25158414221132825 - 18Werme J, van der Sluis S, Posthuma D, de Leeuw CA. An integrated framework for local genetic correlation analysis. Nat Genet. 2022;54(3):274–282. DOI: 10.1038/s41588-022-01017-y
- 19Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, Langenberg C, Golub RM, Loder EW, Gallo V, Tybjaerg-Hansen A, Davey Smith G, Egger M, Richards JB. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. JAMA. 2021;326(16):1614–1621. DOI: 10.1001/jama.2021.18236
- 20Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):
e1001779 . DOI: 10.1371/journal.pmed.1001779 - 21Tobin MD, Minelli C, Burton PR, Thompson JR. Commentary: Development of Mendelian randomization: from hypothesis test to ‘Mendelian deconfounding’. Int J Epidemiol. 2004;33(1):26–29. DOI: 10.1093/ije/dyh016
- 22Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–5528. DOI: 10.1002/sim.3148
- 23Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG. Survival prediction in mesothelioma using a scalable Lasso regression model: Instructions for use and initial performance using clinical predictors. BMJ Open Respir Res. 2018;5(1):
e000240 . DOI: 10.1136/bmjresp-2017-000240 - 24Palmer A, Phapale P, Chernyavsky I, Lavigne R, Fay D, Tarasov A, Kovalev V, Fuchser J, Nikolenko S, Pineau C. FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry. Nat Methods. 2017;14(1):57–60. DOI: 10.1038/nmeth.4072
- 25Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K. Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology. 2022;163(1):222–238. DOI: 10.1053/j.gastro.2022.03.054
- 26wang J, Weng H, Qian Y, Wang Y, Wang L, Wang X, Zhang P, Wang Z. The impact of serum BNP on retinal perfusion assessed by an AI-based denoising optical coherence tomography angiography in CHD patients. Heliyon. 2024;10(8):
e29305 . DOI: 10.1016/j.heliyon.2024.e29305 - 27Chen Y, Yuan Y, Zhang S, Yang S, Zhang J, Guo X, Huang W, Zhu Z, He M, Wang W. Retinal nerve fiber layer thinning as a novel fingerprint for cardiovascular events: Results from the prospective cohorts in UK and China. BMC Med. 2023;21(1):
24 . DOI: 10.1186/s12916-023-02728-7 - 28von Hanno T, Hareide LL, Småbrekke L, Morseth B, Sneve M, Erke MG, Mathiesen EB, Bertelsen G. Macular layer thickness and effect of BMI, body fat, and traditional cardiovascular risk factors: the Tromsø study. Invest Ophthalmol Vis Sci. 2022;63(9):
16 . DOI: 10.1167/iovs.63.9.16 - 29Liu RT, Gao J, Cao S, Sandhu N, Cui JZ, Chou CL, Fang E, Matsubara JA. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54(3):2225–2237. DOI: 10.1167/iovs.12-10849
- 30Steiner M, del Mar Esteban-Ortega M, Muñoz-Fernández S. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: A review. Surv Ophthalmol. 2019;64(6):757–769. DOI: 10.1016/j.survophthal.2019.04.007
- 31Brown EE, DeWeerd AJ, Ildefonso CJ, Lewin AS, Ash JD. Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors. Redox Biol. 2019;24:
101201 . DOI: 10.1016/j.redox.2019.101201 - 32Gabrielle PH. Lipid metabolism and retinal diseases. Acta Ophthalmol. 2022;100 Suppl 269:3–43. DOI: 10.1111/aos.15226
- 33Zarei R, Anvari P, Eslami Y, Fakhraie G, Mohammadi M, Jamali A, Afarideh M, Ghajar A, Heydarzade S, Esteghamati A. Retinal nerve fibre layer thickness is reduced in metabolic syndrome. Diabet Med. 2017;34(8):1061–1066. DOI: 10.1111/dme.13369
- 34Pikuleva IA, Curcio CA. Cholesterol in the retina: the best is yet to come. Prog Retin Eye Res. 2014;41:64–89. DOI: 10.1016/j.preteyeres.2014.03.002
- 35Bhargava M, Ikram MK, Wong TY. How does hypertension affect your eyes? J Hum Hypertens. 2012;26(2):71–83. DOI: 10.1038/jhh.2011.37
- 36Xie H, Pan Z, Xue CC, Chen D, Jonas JB, Wu X, Wang YX. Arterial hypertension and retinal layer thickness: the Beijing Eye Study. Br J Ophthalmol. 2024;108(1):105–111. DOI: 10.1136/bjo-2022-322229
- 37Wei L, Champman S, Li X, Li X, Li S, Chen R, Bo N, Chater A, Horne R. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: A cross-sectional study in China. BMJ Open. 2017;7(10):
e017293 . DOI: 10.1136/bmjopen-2017-017293 - 38Schmid M, Wright MN, Ziegler A. On the use of Harrell’s C for clinical risk prediction via random survival forests. Expert Syst Appl. 2016;63:450–459. DOI: 10.1016/j.eswa.2016.07.018